Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance.
- NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_assertion description "[Another finding showed that flavopiridol treatment induced a substantial AKT-Ser473 phosphorylation in human glioblastoma T98G cell line in contrast to siRNA-mediated inhibition of Cdk9 and Cdk9 combined with Cdk7, whereas siRNA-mediated silencing of Cdk7 caused a minor increase in AKT-Ser473 phosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance.
- NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_assertion evidence source_evidence_literature NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance.
- NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_assertion SIO_000772 22391209 NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance.
- NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_assertion wasDerivedFrom befree-20140225 NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance.
- NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_assertion wasGeneratedBy ECO_0000203 NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP615667.RAgegubGomXySVwS4RvXW4LbFHSNu59SGd0OtTvp4endg130_provenance.